The groundbreaking treatment of this peptide represents a significant development in the care of the condition. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide617402.designi1.com/62728029/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment